IP portfolio growth Specializes in writing and reviewing infringement and validity opinions for patents in molecular genetics, offering opportunities to expand clients' IP portfolios, strengthen freedom-to-operate analyses, and support licensing negotiations.

Biotech focus Experience spans biological, chemical, and medical device technologies with a track record advising pharmaceutical companies, biotech firms, universities, and research institutions on patent strategy and prosecution.

US and foreign strategy Capabilities include preparing and prosecuting U.S. patent applications and handling foreign patent matters, enabling cross-border IP protection for clients with global research and product pipelines.

Funding-ready clients Reported revenue range positions the firm as a mid-size player with potential to upsell premium IP strategy, portfolio audits, and licensing negotiations to growth-stage biotech and pharma clients seeking scalable services.

Expansion opportunities Small-to-mid sized team with extensive external and in-house counsel experience suggests opportunities to bundle services such as secrecy, collaboration agreements, and technology transfer support for university and corporate clients.